Skip to main content

Part of Congenital anomaly statistics 2019

Appendix two: Technical details

Current Chapter

Current chapter – Appendix two: Technical details



Incidence and birth prevalence

Incidence is the total number of new cases of disease occurring in a population in a specified time period, whereas prevalence is the total number of all cases in a population at one point in time. Conventionally, as in this report, congenital anomaly registers report prevalence estimates. This is because a proportion of pregnancies with an anomaly will miscarry spontaneously before being identified. It is also not possible to provide a population estimate of the total number of pregnancies at risk of a congenital anomaly as there is no reliable estimate of the total number of pregnancies, given some result in miscarriage and terminations of pregnancy for fetal anomaly (TOPFA). Prevalence estimates are reported per 10,000 total births (live and stillbirths); these are referred to as birth prevalence estimates even though the pregnancy may not result in a registered birth because of late miscarriage or TOPFA.

 

Confidence intervals

Confidence intervals are calculated around many different types of statistic used in public health analysis. Comparisons are often made between 2 or more different rates. In this report, examples include estimated birth prevalence comparisons between different regions of registration, maternal age category and type of congenital anomaly. Basic statistical testing is undertaken by comparing the confidence intervals of estimated birth prevalence to see if they overlap - with non-overlapping confidence intervals being considered as statistically significantly different.
The confidence intervals used in this report are calculated using the Poisson distribution (Bégaud et al, 2005).

Confidence intervals

 

Denominators

The number of total (live and still) births in England reported by the Office of National Statistics is used to calculate total birth prevalence and live birth prevalence of congenital anomalies. These are obtained from the PHE Data Lake. We also obtain the number of births from each of the UK Crown Dependencies; Isle of Man, Jersey and Guernsey. These are added to the total births for the respective regions; North West and Wessex and also to the overall total births for England.

 

 


Geographical coverage of the NCARDRS regions

NCARDRS is made up of 10 reporting regions in England (Figure 1, main report). Regional boundaries used in this report are the EUROCAT reporting regions for England. To preserve the longitudinal trend, they are consistent with the legacy registers for these regions (East Midlands and South Yorkshire, Northern, South West, Thames Valley and Wessex). Table 1 lists the Local Authorities that are included in each region.

NCARDRS region

Local authorities

East of England

Peterborough

Broxbourne

 

Luton

Dacorum

 

Southend-on-Sea

Hertsmere

 

Thurrock

North Hertfordshire

 

Bedford

Three Rivers

 

Central Bedfordshire

Watford

 

Cambridge

Breckland

 

East Cambridgeshire

Broadland

 

Fenland

Great Yarmouth

 

Huntingdonshire

King’s Lynn and West Norfolk

 

South Cambridgeshire

North Norfolk

 

Basildon

Norwich

 

Braintree

South Norfolk

 

Brentwood

Babergh

 

Castle Point

Ipswich

 

Chelmsford

Mid Suffolk

 

Colchester

St Albans

 

Epping Forest

Welwyn Hatfield

 

Harlow

East Hertfordshire

 

Maldon

Stevenage

 

Rochford

West Suffolk

 

Tendring

East Suffolk

 

Uttlesford

 

East Midlands and South Yorkshire (EMSY)

Amber Valley Ashfield

 Leicester

Lincoln

 

Barnsley

Mansfield

 

Bassetlaw

Melton

 

Balby

Newark and Sherwood

 

Bolsover

North East Derbyshire

 

Boston

North East Lincolnshire

 

Broxtowe

North Kesteven

 

Charnwood

North Lincolnshire

 

Chesterfield

North West Leicestershire

 

Corby

Northampton

 

Daventry

Nottingham

 

Derby

Oadby and Wigston

 

Derbyshire Dales

Rotherham

 

Doncaster

Rushcliffe

 

East Lindsey

Rutland

 

East Northamptonshire

Sheffield

 

Erewash

South Derbyshire

 

Gedling

South Holland

 

Harborough

South Kesteven

 

High Peak

South Northamptonshire

 

Hinckley and Bosworth

Wellingborough

 

Kettering

West Lindsey

London and South East

Medway

Mid Sussex

 

Brighton and Hove

Worthing

 

Eastbourne

City of London

 

Hastings

Barking and Dagenham

 

Lewes

Barnet

 

Rother

Bexley

 

Wealden

Brent

 

Ashford

Bromley

 

Canterbury

Camden

 

Dartford

Croyden

 

Dover

Ealing

 

Gravesham

Enfield

 

Maidstone

Greenwich

 

Sevenoaks

Hackney

 

Shepway

Hammersmith and Fulham

 

Swale

Haringey

 

Thanet

Harrow

 

Tonbridge and Malling

Havering

 

Tunbridge Wells

Hillingdon

 

Elmbridge

Hounslow

 

Epsom and Ewell

Islington

 

Guildford

Kensington and Chelsea

 

Mole Valley

Kingston upon Thames

 

Reigate and Banstead

Lambeth

 

Runnymeade

Lewisham

 

Spelthorne

Merton

 

Surrey Heath

Newham

 

Tandridge

Redbridge

 

Waverley

Richmond upon Thames

 

Woking

Southwark

 

Adur

Sutton

 

Arun

Tower Hamlets

 

Chichester

Waltham Forest

 

Crawley

Wandsworth

 

Horsham

Westminster

Northern

Allerdale

Middlesbrough

 

Carlisle

Newcastle upon Tyne

 

Copeland

North Tyneside

 

County Durham

Northumberland

 

Darlington

Redcar and Cleveland

 

Eden

South Tyneside

 

Gateshead

Stockton-On-Tees

 

Hartlepool

Sunderland

North West

Halton

West Lancashire

 

Warrington

Wyre

 

Blackburn with Darwen

Bolton

 

Blackpool

Bury

 

Cheshire East

Manchester

 

Cheshire West and Chester

Oldham

 

Barrow-in-Furness

Rochdale

 

South Lakeland

Salford

 

Burnley

Stockport

 

Chorley

Tameside

 

Fylde

Trafford

 

Hyndburn

Wigan

 

Lancaster

Knowsley

 

Pendle

Liverpool

 

Preston

St.Helens

 

Ribble Valley

Sefton

 

Rossendale

Wirral

 

South Ribble

 

South West

Bath and North East Somerset

Plymouth

 

Bristol, City of

Sedgemoor

 

Cheltenham

South Gloucestershire

 

Cornwall

South Hams

 

Cotswold

South Somerset

 

East Devon

Stroud

 

Exeter

Swindon

 

Forest of Dean

Taunton Deane Teignbridge

 

Gloucester

Tewkesbury

 

Isles of Scilly

Torbay

 

Mendip

Torridge

 

Mid Devon

West Devon

 

North Devon

West Somerset

 

North Somerset

Wiltshire (excluding Salisbury)

Thames Valley

Aylesbury Vale

South Bucks

 

Bracknell Forest

South Oxfordshire

 

Cherwell

Vale of White Horse

 

Chiltern

West Berkshire

 

Milton Keynes

Windsor and Maidenhead

 

Oxford

Wokingham

 

Reading

Wycombe

 

Slough

 

Wessex

Basingstoke and Deane

North Dorset

 

Bournemouth

Poole

 

Christchurch

Portsmouth

 

East Dorset

Purbeck

 

East Hampshire

Rushmoor

 

Eastleigh

Southampton

 

Fareham

Test Valley

 

Gosport

West Dorset

 

Hart

Weymouth and Portland

 

Havant

Wiltshire (Salisbury only)

 

Isle of Wight

Winchester

 

New Forest

 

West Midlands

Birmingham

Shropshire

 

Bromsgrove

Solihull

 

Cannock Chase

South Staffordshire

 

Coventry

Stafford

 

Dudley

Stoke-on-Trent

 

East Staffordshire

Stratford-on-Avon

 

Herefordshire, County of

Tamworth

 

Lichfield

Telford and Wrekin

 

Malvern Hills

Newcastle-under-Lyme

Walsall

 Warwick

 

North Warwickshire

Wolverhampton

 

Nuneaton and Bedworth

Worcester

 

Redditch

Wychavon

 

Rugby

Wyre Forest

 

Sandwell

 

Yorkshire and Humber

Bradford

Leeds

 

Calderdale

Richmondshire

 

Craven

Ryedale

 

East Riding of Yorkshire

Scarborough

 

Hambleton

Selby

 

Harrogate

Wakefield

 

Kingston upon Hull

York

 

City of Kirkless

 

 

Table 1. Geographical coverage of the NCARDRS regions in this report


Data collection

Congenital anomalies are defined as being present at delivery, originating before birth, and include structural, chromosomal and genetic anomalies. Screening during pregnancy can detect some congenital anomalies, while some are found at birth. Others are detected as a baby grows older.


Congenital anomaly data are collected from a number of different sources including:
• maternity units
• neonatal units
• diagnostic departments (paediatric, neonatal, clinical genetics, antenatal ultrasound, fetal medicine, pathology)
• genetic laboratories
• NHS trust IT departments
• child health systems
• local audit schemes
• disease-specific registers
• neighbouring national registers

 

This multiple source reporting enables NCARDRS to achieve the highest possible ascertainment of congenital anomalies in the population. Much of the focus to date has been on ensuring high ascertainment and completeness of cases nationally and ensuring consistency and standardisation across the country.


A single data management system has been developed and NCARDRS has a growing team of dedicated registration officers and analysts. NCARDRS currently takes electronic data from over 500 NHS providers across the country.

 

Data is collected on all suspected and confirmed congenital anomalies identified in utero, at birth or at any point in childhood. In addition to babies that are liveborn or stillborn that have congenital anomalies, information about TOPFA at any gestation and miscarriages where an anomaly is present is also collected. NCARDRS only report anomalies that are recorded in pregnancies that end in a late miscarriage (20 to 23 weeks gestation) as ascertainment of all miscarriages with congenital anomalies is not possible.


NCARDRS collects information about the mother and child, including postcode of residence, mother’s age, pregnancy length, pregnancy outcome, when and how the anomaly was identified and the details of each anomaly. Some identifiable information is collected on the mother and child but only enough information to avoid duplicate registrations and for the validation of cases, ensuring accurate matching between antenatally diagnosed anomalies and postnatal notifications.


Data quality

All 10 reporting regions have submitted data to the European Surveillance of Congenital Anomalies (EUROCAT) since the 2018 birth year cohort and followed their data quality procedures, ensuring collection of a number of core variables. More information can be found in the EUROCAT Guidelines for data registration. In addition, there is an established national process and system for data collection, processing and quality assurance, adopting internationally approved methods of coding, recording and analysis.

 

Inclusion criteria

All livebirths, fetal deaths with gestational age (GA) greater than or equal to 20 weeks and TOPFA (at any gestational age) with at last one registered anomaly delivered in England are included for reporting.

 

Coding and reporting

NCARDRS codes congenital anomalies according to the paediatric adaptation of ICD-10 produced by the British Paediatric Association (BPA). The BPA classification specifies more clinical terms than ICD-10, and provides greater granularity for analytical purposes through the use of 5th character extensions to many ICD-10 codes. NCARDRS uses the EUROCAT congenital anomaly subgroup categories for reporting. These subgroups use ICD10 codes with the BPA extension to group together conditions by body system and anomaly type. Table 2 reproduces the EUROCAT congenital anomaly subgroup categories. Table 3 lists the exclusions applied to the categories in Table 2.

 

 

Subgroups

ICD10-BPA

Comments

Excluded minor anomalies

All anomalies

Q-chapter, D21.5, D82.1, D18.10, P35.0, P35.1, P37.1

 

Exclude all minor anomalies as specified in exclusion list below

Nervous system

Q00*, Q01*, Q02, Q03*, Q04*, Q05*, Q06*, Q07*

 

Q04.61, Q07.82

Neural tube defects

Q00*, Q01*, Q05*

 

 

Anencephalus and similar

Q00*

 

 

Encephalocele

Q01*

Exclude if associated with anencephalus subgroup

 

Spina Bifida

Q05*

Exclude if associated with anencephalus or encephalocele subgroups

 

Hydrocephalus

Q03*

Exclude hydranencephaly. Exclude association with NTD subgroup

 

Severe Microcephaly

Q02

Exclude association with NTD subgroup

 

Arhinencephaly or holoprosencephaly

Q04.1, Q04.2

 

 

Eye

Q10*-Q15*

 

Q10.1-Q10.3, Q10.5, Q13.5

Anophthalmos or microphthalmos

Q11.0, Q11.1, Q11.2

 

 

Anophthalmos

Q11.0, Q11.1

 

 

Congenital cataract

Q12.0

 

 

Congenital glaucoma

Q15.0

 

 

Ear, face and neck

Q16*, Q17*, Q18*

 

Q17.0-Q17.5, Q17.9, Q18.0-Q18.2, Q18.4- Q18.7, Q18.80, Q18.9

Anotia

Q16.0

 

 

Congenital Heart Defects

Q20*-Q26*

Exclude Patent ductus arteriosus with gestational age (GA) less than 37 weeks

Exclude peripheral pulmonary artery stenosis with GA less than 37 weeks

Q21.11,

Q25.0 if GA less than 37 weeks, Q25.41,

Q25.6 if GA less than 37 weeks, Q26.1

Severe CHD

Q20.0, Q20.1, Q20.3, Q20.4,

Q21.2, Q21.3, Q22.0, Q22.4,

Q22.5, Q22.6, Q23.0, Q23.2,

Q23.3, Q23.4, Q25.1, Q25.2, Q26.2

 

 

Common arterial truncus

Q20.0

 

 

Double outlet right ventricle

Q20.1

 

 

Transposition of great vessels

Q20.3

 

 

Single ventricle

Q20.4

 

 

Ventricular septal defect

Q21.0

 

 

Atrial septal defect

Q21.1

 

Q21.11

Atrioventricular septal defect

Q21.2

 

 

Tetralogy of Fallot

Q21.3

 

 

Tricuspid atresia and stenosis

Q22.4

 

 

Ebstein's anomaly

Q22.5

 

 

Pulmonary valve stenosis

Q22.1

 

 

Pulmonary valve atresia

Q22.0

 

 

Aortic valve atresia or stenosis

Q23.0

 

 

Mitral valve anomalies

Q23.2, Q23.3

 

 

Hypoplastic left heart

Q23.4

 

 

Hypoplastic right heart

Q22.6

 

 

Coarctation of aorta

Q25.1

 

 

Aortic atresia or interrupted aortic arch

Q25.2

 

 

Total anomalous pulm venous return

Q26.2

 

 

Patent ductus arteriosus as only

CHD in term infants (GA

+37 weeks)

Q25.0

Livebirths only

 

Respiratory

Q30.0, Q32*-Q34*

Exclude Q33.6

Q32.0, Q33.1

Choanal atresia

Q30.0

 

 

Cystic adenomatous malformation of lung

Q33.80

 

 

Oro-facial clefts

Q35*-Q37*

Exclude association with holoprosencephaly or anencephaly subgroups

 

Cleft lip with or without cleft palate

Q36*, Q37*

Exclude association with holoprosencephaly or anencephaly subgroups

 

Cleft palate

Q35*

Exclude association with cleft lip subgroup.

Exclude association with holoprosencephaly or anencephaly subgroups

 

Digestive system

Q38*-Q45*, Q79.0

 

Q38.1, Q38.2, Q38.50, Q40.0, Q40.1. Q40.21, Q43.0, Q43.20, Q43.81, Q43.82

Oesophageal atresia with or without tracheo-

oesophageal fistula

Q39.0-Q39.1

 

 

Duodenal atresia or stenosis

Q41.0

Exclude if also annular pancreas subgroup

 

Atresia or stenosis of other parts of small intestine

Q41.1-Q41.8

 

 

Ano-rectal atresia and stenosis

Q42.0-Q42.3

 

 

Hirschsprung's disease

Q43.1

 

 

Atresia of bile ducts

Q44.2

 

 

Annular pancreas

Q45.1

 

 

Diaphragmatic hernia

Q79.0

 

 

Abdominal wall defects

Q79.2, Q79.3, Q79.5

 

 

Gastroschisis

Q79.3

 

 

Omphalocele

Q79.2

 

 

Urinary

Q60*-Q64*, Q79.4

 

Q61.0, Q62.7, Q63.3

Bilateral renal agenesis including Potter syndrome

Q60.1, Q60.6

Exclude unilateral

 

Multicystic Renal dysplasia

Q61.40, Q61.41

 

 

Congenital hydronephrosis

Q62.0

 

 

Bladder exstrophy and/or epispadias

Q64.0, Q64.1

 

 

Posterior urethral valve and/or prune belly

Q64.20, Q79.4

 

 

Genital

Q50*-Q52*, Q54*-Q56*

 

Q52.3, Q52.5, Q52.7, Q55.20, Q55.21

Hypospadias

Q54*

 

 

Indeterminate sex

Q56*

 

 

Limb

Q65*-Q74*

 

Q65.3-Q65.6, Q66.2-Q66.9, Q67.0-Q67.8,

Q68.0, Q68.10, Q68.21, Q68.3-Q68.5, Q74.00

Limb reduction

Q71*-Q73*

 

 

Club foot – talipes equinovarus

Q66.0

 

 

Hip dislocation and/or dysplasia

Q65.0–Q65.2, Q65.80, Q65.81

 

 

Polydactyly

Q69*

 

 

Syndactyly

Q70*

 

 

Other anomalies or syndromes

 

 

 

Skeletal dysplasias

Q74.02, Q77*, Q78.00, Q78.2- Q78.8

 

 

Craniosynostosis

Q75.0

 

 

Congenital constriction bands or amniotic band

Q79.80

 

 

Situs inversus

Q89.3

 

 

Conjoined twins

Q89.4

 

 

Congenital skin disorders

Q80*-Q82*

 

Q82.5, Q82.80

VATER/VACTERL

Q87.26

 

 

Vascular disruption

Q04.35, Q41.1, Q41.2, Q41.8,

 

 

anomalies

Q71.0, Q71.2, Q71.3, Q72.0,

 

Q72.2, Q72.3, Q73.0, Q79.3,

 

Q79.5, Q79.80, Q79.82, Q87.06

Laterality anomalies

Q20.6, Q24.0, Q33.81, Q89.0, Q89.3

 

 

Teratogenic syndromes with malformations

Q86*, P35.0, P35.1, P37.1

 

 

Fetal alcohol syndrome

Q86.0

 

 

Valproate syndrome

Q86.80

 

 

Maternal infections resulting in malformations

P35.0, P35.1, P37.1

 

 

Genetic syndromes +

Q44.71,

Exclude Associations and

 

microdeletions

Q61.90,

sequences

 

Q74.84,

Exclude

 

Q75.1, Q75.4, Q75.81, Q87*, Q93.6, D82.1

Q87.03, Q87.04, Q87.06, Q87.08, Q87.24, Q87.26

Chromosomal

Q90*-Q92*, Q93*, Q96*- Q99*

Exclude microdeletions Q93.6

 

Down’s syndrome

Q90*

 

 

Patau’s syndrome

Q91*4-Q91*7

 

 

Edwards’ syndrome

Q91*0-Q91*3

 

 

Turner’s syndrome

Q96*

 

 

Klinefelter’s syndrome

Q98*0-Q98*4

 

 

Table 2. EUROCAT congenital anomaly subgroups

 

 

 

 

 

 

Specified ICD10-BPA – if present

Head

 

Aberrant scalp hair patterning

 

Brachycephaly

 

Flat occiput

 

Depressions in skull, lacunar skull, temporal flattening

Q67.40

Dolichocephaly

Q67.2

Plagiocephaly – head asymmetry

Q67.3

Third fontanelle

 

Macrocephalus

Q75.3

Facial asymmetry

Q67.0

Compression facies

Q67.1

Other cong deformities of skull, face and jaw (including all types of abnormally shaped skull without synostosis)

Q67.4

Skull, late closure

 

Dysmorphic face

Broad, prominent forehead

Q18.9

Coarse facies

 

Flattened face

 

Frontal bossing or wide forehead

 

Mid face hypoplasia

 

Pointed facies

 

Round head shape

 

Sloping forehead

 

Metopic ridge, high metopic suture

 

Wormian bones

 

Bony occipital spur

 

Eyes

 

Anisocoria

 

Dacryocystocele

H04.6

Epicanthic folds

Q18.9

Epicenthus inversus

Q18.9

Exophthalmos

H05.2

Upward slanting palpebral fissures

Q10.3

Downward slanting palpebral fissures

Q10.3

Short palpebral fissures

Q18.9

Congenital ectropion

Q10.1

Congenital entropion

Q10.2

Other congenital malformations of eyelid

Q10.3

Oval shaped pupils

 

Prominent or protruding eyes

H05.2

Dystopia canthorum

Q18.9

Hypertelorism

Q75.2

Hypotelorism

Q18.9

Stenosis of stricture of lacrimal duct

Q10.5

Synophrys

Q18.80

Blue sclera

Q13.5

Crocodile tears

Q07.82

Ears

 

Primitive shape

Q17.3

Lack of helical fold

Q17.3

Asymmetric size

Q17.3

Posterior angulation

Q17.3

Microtia or small ears

Q17.2

Macrotia

Q17.1

Protuberant ears

Q17.3

Absent tragus

 

Double lobule

Q17.0

Accesorry auricle, preauricular appendage, tag or lobule

Q17.0

Auricular pit

 

Pointed ear, Vulcan ear, simple ear

Q17.3

Preauricular sinus or cyst

Q18.1

Narrow external auditory meatus

 

Low set ears

Q17.4

Bat ear, prominent proturberant ear

Q17.5

Congenital absence of ear lobe

 

Darwin’s tubercle

 

Unspecified and minor malformation of ear

Q17.9

Nose

 

Small or hypoplastic nares

Q18.9

Notched alas

 

Anteverted nares

Q18.9

Bifid tip of nose

Q18.9

Broad nasal root, anomaly of nasal root

Q18.9

Depressed nasal bridge

Q18.9

Deviation of nasal septum

Q67.41

Dysmorphic nose

Q18.9

Flat nose

Q18.9

Flattened nasal bridge

Q18.9

Pinched nose

Q18.9

Prominent nasal bridge

Q18.9

Saddle nose

Q18.9

Small pointed nose

Q18.9

Underdeveloped nasal bones

Q18.9

Upturned nose

Q18.9

Wide nasal root

Q18.9

Oral regions

 

Borderline small mandible or minor micrognathia

 

Aberrant frenula

 

Absentor hypoplasia depressor anguli oris (asymmetric crying face)

 

Alveolar crest

 

Anomalies of philtrum, elongated philtrum

Q18.9

Bifid uvula or cleft uvula

Q35.7

Borderline small mandible or minor micrognathia

 

Disturbances in tooth eruption

 

Enamel hypoplasia

 

Glossoptosis

 

Malformed teeth

 

High arched palate

Q38.50

Tongue tie or cyst of tongue

Q38.1

Macroglossia or hemi-hypertrophy of tongue

Q38.2

Macrostomia

Q18.4

Malformed teeth

 

Microstomia

Q18.5

Macrocheilia

Q18.6

Microcheilia

Q18.7

Microglossia

 

Microstomia

Q18.9

Mid-oral tongue position

 

Neonatal teeth

 

Prominent jaw

Q18.9

Retrognathia or receding chin

Q67.4

Short philtrum

Q18.9

Thin lips

Q18.9

Ranula

 

Neck

 

Broad neck

Q18.9

Congenital thymic hypoplasia

 

Short neck

Q18.9

Mild webbed neck

 

Sinus, fistula or cyst of branchial cleft

Q18.0

Thymus involution

 

Thyreoglossal cyst

 

Preauricular sinus or cyst

Q18.1

Other branchial cleft malformations

Q18.2

Congenital malformation of face and neck, unspecified

Q18.9

Torticollis

Q68.0

Hands

 

Duplication of thumbnail

 

Arachnodactyly

 

Enlarged or hypertrophic nails

Q84.5

Single or abnormal palmar crease

Q82.80

Unusual dermatoglyphics

 

Clinodactyly (5th finger)

Q68.10

Short fingers (4. 5. th finger)

 

Accessorry carpal bones

Q74.00

Other congenital malformations of nails

Q84.6

Overlapping fingers

 

Small fingers

 

Subluxation of phalangeal bones

 

Feet or limb

 

Bulbous toes

 

Syndactyly (second to third toes)

 

Gap between toes (first to second)

 

Short great toe

 

Recessed toes (fourth, fifth)

 

Enlarged or hypertrophic nails

Q84.5

Prominent calcaneus

 

Clicking hip, subluxation of unstable hip

Q65.3-Q65.6

Metatarsus varus or metatarsus adductus

Q66.2

Hallux varus – other cong varus deformities of feet

Q66.3

Talipes or pes calcaneovalgus

Q66.4

Talipes calcaneovarus

Q66.1

Congenital pes planus

Q66.5

Hip dysplasia and other specified or unspecified hip anomalies

Q65.8, Q65.9

Metatarsus varus – other cong valgus deformities of feet

Q66.6

Overlapping toes

 

Pes cavus

Q667

Rocker bottom feet

Q6680

Clubfoot of postural origin – other cong deformities of feet

Q668

Congenital deformity of feet, unspecified

Q669

Skin

 

Hemangioma if no treatment is required

 

Pigmented naevus – cong non-neoplastic naevus

Q82.5

Neavus flammeus

Q82.50

Strawberry naevus

Q82.51

Lymphangioma if no treatment is required

 

Angioma

 

Persistent lanugo

 

Mongoloid spot (whites)

Q82.52

Depigmented spot

 

Unusual placement of nipples or wide spaced nipples

 

Accessory nipples

Q83.3

Accessory skin tags

Q82.81

Cafe-au-lait spot

 

Epibulbar dermoid

 

Heterochromia of hair

 

Hypoplasia of toe nails

Q84.6

Skeletal

 

Cubitus valgus

 

Prominent sternum or pectus carinatum

Q67.7

Prominent sternum

 

Depressed sternum or pectus excavatum

Q67.6

Sternum bifidum

Q76.71

Shieldlike chest, other cong deformities of chest

Q67.8

Congenital deformity of spine

Q67.5

Genua valgum

 

Genus varum

 

Genu recurvatum

Q68.21

Duplication of ribs

 

Congenital bowing of femur

Q68.3

Congenital bowing of fibula and tibia

Q68.4

Congenital bowing of long bones of leg, unspecified

Q68.5

Congenital bowing of upper limb

 

No ossification of os coccyx

 

Ovoid configuration of vertebrae

 

Spina bifida occulta

Q76.0

Sacral dimple

L05.9

Cervical rib

Q76.5

Fused rib, single

 

Absence of rib or hypoplastic rib

Q76.60

Accessory rib

Q76.62

Congenital lordosis, postural

Q76.43

Abortive 12th rib

 

Coronal clefts of vertebrae, incomplete

 

Bipartite vertebrae

 

Bifid ribs

 

Brain

 

Arachnoid cysts

 

Asymmetric ventricles, normal size

 

Banana shaped cerebellum

 

Cerebellar hypoplasia, mild

 

Cerebral atrophy

 

Cyst of septum pellucidum

 

Enlarged cisterna magna, isolated

 

Jaw-winking syndrome, Marcus Gunn's syndrome

Q07.80

Periventricular leukomalacia

 

Single congenital cerebral cyst

Q04.61

Thin or hypoplastic corpus callosum

 

Ventriculomegaly less than 15 mm

 

Choroid plexus cysts

 

Anomalies of septum pellucidum

 

Cardiovascular

 

Absence or hypoplasia of umbilical artery, single umbilical artery

Q27.0

Absence of vena cava superior

 

Functional or unspecified cardiac murmur

R01.1

Cardiomegaly

I51.7

Cardiomyopathy

I42.9

Deviation of the heart axis

 

Patent ductus arteriosus if GA less than 37 weeks

Q25.0 if GA less than 37 weeks

Peripheral pulmonary artery stenosis

Q25.6 if GA less than 37 weeks

Patent or persistent foramen ovale

Q21.11

Persistent left superior vena cava

Q26.1

Persistent right aortic arch

Q25.41

Persistent right umbilical vein

 

Congenital heart block

Q24.6

Pulmonary

 

Accessory lobe of lung

Q33.1

Congenital laryngeal stridor

Q31.4

Laryngomalacia

Q31.40

Tracheomalacia

Q32.0

Azygos lobe of lung

Q33.10

Bronchomalacia

Q32.2

Single cyst of the lung

Q33.00

Hyperplasia of thymus

 

Pleural effusion

 

Pulmonary hypoplasia, secondary

 

Relaxation of diaphragm

 

Thymus involution

 

Vocal cord palsy

 

Gastro-intestinal

 

Hiatus hernia

Q40.1

Abdominal cyst not needing surgery

 

Accessory spleen

 

Choledochal cyst

Q44.4

Congenital adrenal hypoplasia

Q89.11

Congenital cholestasis

 

Congenital mesenteric cyst

Q45.83

Cyst of spleen

 

Dilatation of intestine

 

Hepatomegaly

R16.0

Liver cyst

 

Plica of anus

 

Splenomegaly

 

Pyloric stenosis

Q400

Diastasis recti

 

Umbilical hernia

 

Inguinal hernia

K40.9

Meckel’s diverticulum

Q43.0

Functional gastro-intestinal disorders

Q40.21, Q43.20, Q43.81, Q43.82

Transient choledochal cyst

 

Anterior anus without surgery

 

Renal

 

Vesico-ureteral-renal reflux

Q62.7

Enlarged or thickened bladder

 

Hydronephrosis with a pelvis dilatation less than 10 mm

 

Hyperplastic and giant kidney

Q63.3

Single renal cyst

Q61.0

External genitals

 

Deficient or hooded foreskin

 

Undescended testicle

Q53*

Unspecified ectopic testis

 

Retractile testis

Q55.20

Hydrocele of testis

 

Phymosis

 

Bifid scrotum

Q55.21

Buried penis

 

Congenital chordee

Q54.4

Congenital adrenogenital disorders

E25.0

Congenital malformation of vulva

Q52.7

Congenital torsion of ovary

Q50.2

Curvature of penis

 

Hypoplasia of penis or micropenis

 

Hymen imperforate

Q52.3

Fusion of labia

Q52.5

Prominent labia minora

 

Enlarged clitoris

 

Vaginal skin tag

 

Cysts of vulva

 

Transient ovarian cyst

 

Developmental ovarian cyst(s)

Q50.1, Q50.10, Q50.11

Embryonic cyst of broad ligament

Q50.5

Foreskin tethered to the scrotum

N47

Hypertrophy of hymen

 

Phimosis

N47

Seminal vesicle cyst

 

Testicular torsion

N44

Other

 

Congenital malformation, unspecified

Q89.9

Chromosomal

 

Balanced chromosomal rearrangements

Q95*

Balanced translocations or inversions in normal individuals

 

Balanced autosomal rearrangement in abnormal individual

Q95.2

Individuals with marker heterochromatin

 

Individuals with autosomal fragile site

 

Table 3. List of exclusions

 


Down’s syndrome, Edwards’ syndrome and Patau’s syndrome

Source data and completeness

Data in electronic form are regularly sent to NCARDRS by every NHS cytogenetic laboratory in England, giving complete national ascertainment from this data feed. Laboratories follow a specific case definition, to ensure national consistency and data quality. Data are supplied for antenatal and postnatal testing (the latter category including fetal losses as well as livebirths), and for all test methods used in cytogenetics laboratories.

 

Inclusion and exclusion criteria

All babies with Down’s syndrome, Edwards’ syndrome or Patau’s syndrome delivered in 2019 according to the case definition previously described with a confirmed cytogenetic laboratory diagnosis provided as part of care from NHS and private providers who submit data to NCARDRS are included within this report. This includes results obtained from conventional karyotyping (full or targeted), rapid aneuploidy testing (usually by FISH or QF-PCR), or microarray analysis. All specimen types are included, including prenatal (amniocentesis, chorionic villus sampling, fetal blood), postnatal (blood, buccal swab) and postmortem (solid tissue). Babies with a positive non-invasive prenatal testing (NIPT) and a clinical suspicion of Down’s syndrome, Edwards’ syndrome or Patau’s syndrome based on postnatal phenotype, but with no further testing, are also included in this report.

Last edited: 20 September 2024 11:10 am